The Cost-Utility of Photodynamic Therapy in Eyes With Neovascular Macular Degeneration—A Value-Based Reappraisal With 5-Year Data-Reference-Cited by-同舟云学术

The Cost-Utility of Photodynamic Therapy in Eyes With Neovascular Macular Degeneration—A Value-Based Reappraisal With 5-Year Data

Published:2005-10 Issue:4 Volume:140 Page:679.e1-679.e10
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

Brown Gary C.,Brown Melissa M.,Campanella Joseph,Beauchamp George R.

Publisher

Elsevier BV

Subject

Ophthalmology

Reference46 articles.

1. Ten-year incidence and progression of age-related maculopathy;Klein;Ophthalmology,2002

2. Prevalence of age-related macular degeneration in the United States;Friedman;Arch Ophthalmol,2004

3. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials;Arch Ophthalmol,1993

4. Brown GC, Brown MM, Sharma S, Roth Z, Campanella J, Beauchamp G. The burden of age-related macular degeneration. A value-based analysis. Curr Opin Ophthalmol. Forthcoming.

5. Difference between ophthalmologist and patient perceptions of quality-of-life associated with age-related macular degeneration;Brown;Can J Ophthalmol,2000

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From molecules to nanovectors: Current state of the art and applications of photosensitizers in photodynamic therapy;International Journal of Pharmaceutics;2021-07

2. A Systematic Review of Economic Studies Evaluating Ophthalmic Drugs: An Analysis of the Health-state Utilities;Ophthalmic Epidemiology;2020-07-21

3. A systematic review on the quality, validity and usefulness of current cost-effectiveness studies for treatments of neovascular age-related macular degeneration;Acta Ophthalmologica;2018-06-04

4. Titania and silica nanoparticles coupled to Chlorin e6 for anti-cancer photodynamic therapy;Photodiagnosis and Photodynamic Therapy;2018-06

5. SOCIETAL COSTS ASSOCIATED WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN THE UNITED STATES;Retina;2016-02